Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis

Launched by RENJI HOSPITAL · Nov 6, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at different methods for treating a condition called deep vein thrombosis (DVT), which is when a blood clot forms in a deep vein, often in the legs. The researchers want to compare a newer technique that uses a specific access point in the leg with the traditional method to see if both can effectively treat DVT. The goal is to find out if one method is better than the other for patients with this condition.

To join the study, participants need to be between 18 and 85 years old and have experienced DVT within the last 14 days. They must also be willing to sign a consent form to participate. However, certain individuals, like those with allergies to specific medications or who are pregnant, won't be eligible. If someone participates, they can expect to undergo a procedure called percutaneous mechanical thrombectomy, which is a minimally invasive treatment to remove the blood clot. This trial is currently recruiting participants, and it aims to gather important information that could help improve DVT treatment in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age between 18-85 years old;
• • 2. Acute DVT occurred no more than 14 days since the onset of disease;
• • 3. DVT treated by percutaneous mechanical thrombectomy
• • 4. Informed consent signed by patients.
• Exclusion Criteria:
• • 1. Patients who are known to be allergic to heparin, low molecular weight heparin, or contrast agent;
• • 2. Women during pregnancy and lactation;
• • 3. Patients with other diseases that may cause difficulty in the study or significantly shorten the life expectancy of patients (\<6 months);
• • 4. Patients who are unable or unwilling to participate in the study.